Ductal adenocarcinoma of the prostate gland: Difference between revisions
Jump to navigation
Jump to search
fix image |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 9: | Line 9: | ||
| LMDDx = [[acinar adenocarcinoma of prostate]], [[prostatic-type polyp]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]] | | LMDDx = [[acinar adenocarcinoma of prostate]], [[prostatic-type polyp]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]] | ||
| Stains = | | Stains = | ||
| IHC = chromogranin A +ve, p53 +ve, PSA +ve | | IHC = chromogranin A +ve, p53 +ve, PSA +ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
| Line 90: | Line 90: | ||
Others:<ref name=pmid20368883>{{Cite journal | last1 = Kumar | first1 = A. | last2 = Mukherjee | first2 = SD. | title = Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment. | journal = Can Urol Assoc J | volume = 4 | issue = 2 | pages = E50-4 | month = Apr | year = 2010 | doi = | PMID = 20368883 }}</ref> | Others:<ref name=pmid20368883>{{Cite journal | last1 = Kumar | first1 = A. | last2 = Mukherjee | first2 = SD. | title = Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment. | journal = Can Urol Assoc J | volume = 4 | issue = 2 | pages = E50-4 | month = Apr | year = 2010 | doi = | PMID = 20368883 }}</ref> | ||
*PSA +ve. | *PSA +ve. | ||
==Sign out== | |||
===Comment about small amount of ductal adenocarcinoma=== | |||
<pre> | |||
A small amount of ductal-type adenocarcinoma of the prostate is seen; it represents approximately 5% of the tumour by volume and is of no particular prognostic significance. As the volume of the ductal-type adenocarcinoma is small, the case is classified as acinar adenocarcinoma. | |||
</pre> | |||
==See also== | ==See also== | ||